Ignite Creation Date:
2025-12-24 @ 4:28 PM
Ignite Modification Date:
2026-06-03 @ 5:19 AM
Study NCT ID:
NCT02130466
Status:
COMPLETED
Last Update Posted:
2022-08-01
First Post:
2014-05-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions: